Table 2.
Frequency of MN and CA in bone marrow cells simultaneously exposed to PM and OLE
| Treatments | Values | |
|---|---|---|
| Number of MNPCE per animal | Number of CAs per animal | |
| Group A (control) | 0.46 ± 0.22a | 1.82 ± 0.46a |
| Group B (OLE; 500 mg kg−1) | 0.48 ± 0.25a | 1.76 ± 0.55a |
| Group C (PM; 60 mg kg−1) | 3.85 ± 1.14c | 4.47 ± 0.87c |
| Group D (OLE plus PM) | 1.54 ± 0.73b | 2.66 ± 0.81b |
(Values are means ± SD of five experiments. Means shown by the same letter are not significantly different from each other at a level of 5%, using Duncan’s test. For example, the means shown by the letter b is different from a or c. In other words, the means having the different letters are different from each other)
MNPCE micronucleated polychromatic erythrocytes, CA chromosomal aberrations, chromatid/chromosome gaps chromatid/chromosome breaks and centric fusions or fragments were considered as same in CA assay